Pioneering Center for Cell and Gene Therapies at Papanikolaou Hospital
A significant development in the healthcare sector is taking place in our country, as the creation of a new Center for Cell and Gene Therapies at the Papanikolaou General Hospital of Thessaloniki has been announced.
This new center aims to provide specialized medical services, utilizing the most modern methods of biotechnology. This investment is expected to significantly strengthen the capabilities of the national health system in treating serious diseases.
Within the framework of the new design, the hospital will begin, for the first time in Greece, the administration of cell therapies to patients suffering from multiple myeloma. This is a critical innovation, as these specific therapies offer new hope to patients who did not respond to traditional treatment methods.
The operation of the center constitutes a major step for the medical community of Greece, as it brings the country to the center of modern medical developments. Patients will now have access to high-level specialized treatments within Greek borders, avoiding the need to travel abroad.
This initiative is expected to upgrade the provided health services and serve as a model for future investments in the field of research and the clinical application of new therapies in our country.